MasR agonist AVE0991 ameliorates EAE: potential involvement of the Nrf2-dependent TLR4/NF-κB/NLRP3 pathway. // Emerging Trends in Drugs, Addictions, and Health. – URL: https://www.sciencedirect.com/science/article/pii/S0028390826004405?dgcid=rss_sd_all
MasR agonist AVE0991 ameliorates EAE: potential involvement of the Nrf2-dependent TLR4/NF-κB/NLRP3 pathway. Emerging Trends in Drugs, Addictions, and Health. https://www.sciencedirect.com/science/article/pii/S0028390826004405?dgcid=rss_sd_all
“MasR agonist AVE0991 ameliorates EAE: potential involvement of the Nrf2-dependent TLR4/NF-κB/NLRP3 pathway.” Emerging Trends in Drugs, Addictions, and Health.
@article{article13956,
title = {MasR agonist AVE0991 ameliorates EAE: potential involvement of the Nrf2-dependent TLR4/NF-κB/NLRP3 pathway},
journal = {Emerging Trends in Drugs, Addictions, and Health},
url = {https://www.sciencedirect.com/science/article/pii/S0028390826004405?dgcid=rss_sd_all}
}
Publication date: 1 February 2027 Source: Neuropharmacology, Volume 303 Author(s): Ran Qiao, Benjamin B. Johnson, Michelle Doyle, Abraham A. Palmer, Giordano de Guglielmo, Marsida Kallupi